
“In terms of technology, all cell and gene therapy facilities should feature sufficient isolator capacity, Dasburg says. “Isolators are probably the number one investment to make. Too many people are trying to work five people in full dress in a small room attempting to manufacture in a hands-on traditional way when isolation and automation could help immensely.”
– Darren Dasburg